[1]
S. K HEGAZY, T. A ELBEDEWY, and H. M SAMI, “EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Asian J Pharm Clin Res, vol. 13, no. 3, pp. 172–179, Mar. 2020.